Malcolm John, MD

CFAR Leadership Positions

Publications

  1. Clark T, Marquez C, Hare CB, John MD, Klausner JD. Methamphetamine Use, Transmission Risk Behavior and Internet Use Among HIV-Infected Patients in Medical Care, San Francisco, 2008. AIDS Behav. 2012 Feb; 16(2):396-403. http://www.ncbi.nlm.nih.gov/pubmed/21190073
  2. Marquez C, Mitchell SJ, Hare CB, John M, Klausner JD. Methamphetamine use, sexual activity, patient-provider communication, and medication adherence among HIV-infected patients in care, San Francisco 2004-2006. AIDS Care. 2009 May; 21(5):575-82. http://www.ncbi.nlm.nih.gov/pubmed/19444665
  3. Robinson CA, Cocohoba J, MacDougall C, John MD, Guglielmo BJ. Discordance between ambulatory care clinic and community pharmacy medication databases for HIV-positive patients. J Am Pharm Assoc (2003). 2007 Sep-Oct; 47(5):613-5. http://www.ncbi.nlm.nih.gov/pubmed/17848351
  4. Flam M, John M, Pajak TF, Petrelli N, Myerson R, Doggett S, Quivey J, Rotman M, Kerman H, Coia L, Murray K. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. J Clin Oncol. 1996 Sep; 14(9):2527-39. http://www.ncbi.nlm.nih.gov/pubmed/8823332
  5. John M, Pajak T, Flam M, Hoffman J, Markoe A, Wolkov H, Paris K. Dose escalation in chemoradiation for anal cancer: preliminary results of RTOG 92-08. Cancer J Sci Am. 1996 Jul-Aug; 2(4):205-11. http://www.ncbi.nlm.nih.gov/pubmed/9166533